THE BABRAHAM INSTITUTE

03011737
Active Cambridge

Other research and experimental development on natural sciences and engineering

361 employees website.com
Life sciences and medical technology Other research and experimental development on natural sciences and engineeringPost-graduate level higher education
T

THE BABRAHAM INSTITUTE

03011737

Other research and experimental development on natural sciences and engineering

Founded 19 Jan 1995 Active Cambridge, United Kingdom 361 employees website.com
Life sciences and medical technology Other research and experimental development on natural sciences and engineeringPost-graduate level higher education

Previous Company Names

THE BABRAHAM INSTITUTE LIMITED 3 May 1995 — 3 Nov 1995
ASPECTRIGHT LIMITED 19 Jan 1995 — 3 May 1995
Accounts Submitted 30 Dec 2025 Next due 31 Dec 2026 6 months remaining
Confirmation Submitted 19 Feb 2026 Next due 2 Feb 2027 7 months remaining
Net assets £155M £4M 2024 year on year
Total assets £166M £6M 2024 year on year
Total Liabilities £12M £2M 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Babraham Hall Babraham Cambridge Cambridgeshire CB22 3AT

Telephone

0800 000 0000

Website

www.example.com

Full company profile for THE BABRAHAM INSTITUTE (03011737), an active life sciences and medical technology company based in Cambridge, United Kingdom. Incorporated 19 Jan 1995. Other research and experimental development on natural sciences and engineering. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Apr → 31 Mar 2025
Type group
Next accounts 31 Mar 2026
Due by 31 Dec 2026 6 months remaining

Balance Sheet & P&L (2014–2024)

Cash in Bank

£20.21M

Decreased by £3.20M (-14%)

Net Assets

£154.89M

Decreased by £3.84M (-2%)

Total Liabilities

£11.58M

Decreased by £1.95M (-14%)

Turnover

£47.50M

Increased by £878.00k (+2%)

Employees

361

Increased by 5 (+1%)

Debt Ratio

7%

Decreased by 1 (-13%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Mar Year End
2024
31 Mar Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Grants 52

Investors (0)

No investor information available

Officers

Officers

2 active 1 resigned
Status
Jones, Simon JohnSecretaryUnknownUnknown1 Mar 2013Active
Lehner, Paul Joseph, ProfessorDirectorBritishEngland641 Oct 2023Active

Shareholders

Shareholders (0)

No shareholder data available

Persons with Significant Control

Persons with Significant Control (0)

0 Active 18 Ceased

Geoffrey Hope-terry

Ceased 31 Dec 2017

Ceased

Professor Anne Ferguson-smith

Ceased 31 Dec 2020

Ceased

Professor Clive Page

Ceased 31 Dec 2020

Ceased

Professor Gordon Brown

Ceased 7 Sept 2021

Ceased

Alexandra Zoe Pygall

Ceased 7 Sept 2021

Ceased

Professor Nicholas Clwyd Jones

Ceased 7 Sept 2021

Ceased

Geoffrey Ernest Braham

Ceased 7 Sept 2021

Ceased

Professor Doreen Cantrell

Ceased 31 Dec 2020

Ceased

Professor Michael Wakelam

Ceased 31 Mar 2020

Ceased

James Michael Briscoe

Ceased 7 Sept 2021

Ceased

Professor David Kipling

Ceased 11 Jun 2020

Ceased

Graham Peter Allen

Ceased 7 Sept 2021

Ceased

Lynne Christine Gailey

Ceased 7 Sept 2021

Ceased

Paul Johnson

Ceased 30 Jun 2017

Ceased

Alan Paul Watt

Ceased 31 Mar 2017

Ceased

Professor Peter Rigby

Ceased 7 Sept 2021

Ceased

Anthony James Clare

Ceased 31 Dec 2020

Ceased

Peter Joseph Parker

Ceased 7 Sept 2021

Ceased

Group Structure

Group Structure

THE BABRAHAM INSTITUTE Current Company

Charges

Charges

No charges registered

Properties

Properties

3 leasehold 3 total
AddressTenurePrice PaidDate Added
The Babraham Institute, Cambridge Road, Cambridge (CB2 4AT) SOUTH CAMBRIDGESHIRE
Leasehold-20 May 2020
The Babraham Institute, Cambridge Road, Babraham, Cambridge (CB2 4AT) SOUTH CAMBRIDGESHIRE
Leasehold-28 Aug 2019
Building 580, Babraham Research Campus, Cambridge Road, Babraham, Cambridge SOUTH CAMBRIDGESHIRE
Leasehold-23 Dec 2015
The Babraham Institute, Cambridge Road, Cambridge (CB2 4AT)
Leasehold
Added 20 May 2020
District SOUTH CAMBRIDGESHIRE
The Babraham Institute, Cambridge Road, Babraham, Cambridge (CB2 4AT)
Leasehold
Added 28 Aug 2019
District SOUTH CAMBRIDGESHIRE
Building 580, Babraham Research Campus, Cambridge Road, Babraham, Cambridge
Leasehold
Added 23 Dec 2015
District SOUTH CAMBRIDGESHIRE

Documents

Company Filings

DateCategoryDescriptionDocument
17 Apr 2026OfficersAppointment of Dr Sharon Anne Tooze as director on 1 Jan 2026
19 Feb 2026Confirmation StatementConfirmation statement made on 19 Jan 2026 with no updates
16 Feb 2026OfficersAppointment of Professor Paul Lehner as director
30 Dec 2025AccountsAnnual accounts made up to 31 Mar 2025
19 Mar 2025OfficersTermination of James Michael Briscoe as director on 12 Mar 2025
17 Apr 2026 Officers

Appointment of Dr Sharon Anne Tooze as director on 1 Jan 2026

19 Feb 2026 Confirmation Statement

Confirmation statement made on 19 Jan 2026 with no updates

16 Feb 2026 Officers

Appointment of Professor Paul Lehner as director

30 Dec 2025 Accounts

Annual accounts made up to 31 Mar 2025

19 Mar 2025 Officers

Termination of James Michael Briscoe as director on 12 Mar 2025

Recent Activity

Latest Activity

Appointment of Dr Sharon Anne Tooze as director on 1 Jan 2026

2 months ago on 17 Apr 2026

Confirmation statement made on 19 Jan 2026 with no updates

4 months ago on 19 Feb 2026

Appointment of Professor Paul Lehner as director

4 months ago on 16 Feb 2026

Annual accounts made up to 31 Mar 2025

5 months ago on 30 Dec 2025

Termination of James Michael Briscoe as director on 12 Mar 2025

1 years ago on 19 Mar 2025